Changes in folate concentration in Yoshida sarcoma after administration of leucovorin or cisplatin Kenji OmuraTakuro MisakiTetsuhiko Shirasaka Original Article Pages: 183 - 187
Vinblastine and erythromycin: an unrecognized serious drug interaction Sheldon W. TobeLillian L. SiuEllen Warner Original Article Pages: 188 - 190
Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines Lilibeth V. Ramilo-TornoVassilios I. Avramis Original Article Pages: 191 - 199
In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice Yuji HeikeMinako TakahashiNagahiro Saijo Original Article Pages: 200 - 204
Phase I study of phosphonacetyl-l-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer Alexandre HageboutrosAndre RogatkoPeter J. O'Dwyer Original Article Pages: 205 - 212
Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat Barry J. CusackStephan P. YoungRichard D. Olson Original Article Pages: 213 - 218
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization Marcel de ForniGuy G. ChabotGonzalo Recondo Original Article Pages: 219 - 224
Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin S. NaitoT. UedaY. Fujisawa Original Article Pages: 225 - 229
Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts Eisaku UetaTokio OsakiTetsuya Yamamoto Original Article Pages: 230 - 236
Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks Laurence J. C. van WarmerdamJaap VerweijJos H. Beijnen Original Article Pages: 237 - 245
Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors Gilles CatimelRégis CoquardMichel Clavel Clinical Trial Report Pages: 246 - 248
Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C Diego TummarelloFrancesco GrazianoRiccardo Cellerino Clinical Trials Report Pages: 249 - 253
Effects of storage on the binding of carboplatin to plasma proteins Kadir ErkmenMerrill J. EgorinJames H. Doroshow Short Communication Pages: 254 - 256
Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin Paul PounaSimone Bonoron-AdèleJacques Robert Short Communication Pages: 257 - 261
Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU Achim Magull-SeltenreichWalter Jens Zeller Short Communication Pages: 262 - 266
The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells Leonard WarrenAnna MalarskaJean-Claude Jardillier Short Communication Pages: 267 - 269